PARP inhibitor resistance: the underlying mechanisms and clinical implications.
Mol Cancer. 2020 Jun 20;19(1):107. doi: 10.1186/s12943-020-01227-0.
Mol Cancer. 2020.
PMID: 32563252
Free PMC article.
Review.